← Back to Clinical Trials
Recruiting NCT05365815

NCT05365815 Melanated Group Midwifery Care (MGMC)

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05365815
Status Recruiting
Phase
Sponsor University of Illinois at Chicago
Condition Pregnancy Complications
Study Type INTERVENTIONAL
Enrollment 432 participants
Start Date 2022-06-08
Primary Completion 2026-05-15

Eligibility & Interventions

Sex Female only
Min Age 15 Years
Max Age 49 Years
Study Type INTERVENTIONAL
Interventions
Melanated Group Midwifery Care

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 432 participants in total. It began in 2022-06-08 with a primary completion date of 2026-05-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study is being conducted to determine if a multi-level intervention for delivering maternity care can improve patient trust and engagement among Black birthing people.

Eligibility Criteria

Inclusion criteria for patients: * pregnant women who self-identify as Black on a standard prenatal intake form * less than 20 weeks pregnant * 15 years old or older * present to the general obstetrics group at the University of Chicago Medical Center for their new prenatal visit * speak and understand English Inclusion criteria for providers: • All black midwives, care coordinators, and community postpartum doulas at the University of Chicago are eligible to participate. Exclusion criteria for patients: * having a condition for which they present to a higher level of obstetrics care (e.g., maternal fetal medicine) for their new prenatal visit * having a cognitive issue that impairs their ability to give informed consent.

Contact & Investigator

Central Contact

Kylea L Liese, PhD

✉ kylea3@uic.edu

📞 3129961867

Principal Investigator

Stacie L Geller, PhD

PRINCIPAL INVESTIGATOR

University of Illinois at Chicago

Frequently Asked Questions

Who can join the NCT05365815 clinical trial?

This trial is open to female participants only, aged 15 Years or older, up to 49 Years, studying Pregnancy Complications. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05365815 currently recruiting?

Yes, NCT05365815 is actively recruiting participants. Contact the research team at kylea3@uic.edu for enrollment information.

Where is the NCT05365815 trial being conducted?

This trial is being conducted at Chicago, United States.

Who is sponsoring the NCT05365815 clinical trial?

NCT05365815 is sponsored by University of Illinois at Chicago. The principal investigator is Stacie L Geller, PhD at University of Illinois at Chicago. The trial plans to enroll 432 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology